Save time and get answers to complex questions with AI chat
Mebendazole ingredients?What is dabrafenib mesylate msn patent issue?The expiration date of the key patent for guselkumab?Dabrafenib patent expiration date novartis gsk composition matter?Quartette side effects?
See the DrugPatentWatch profile for aspirin
What are the key chemical modifications made to aspirin for current antiplatelet use? Current antiplatelet formulations, such as acetylsalicylic acid or ASA (aspirin) and its derivatives, contain a single chemical modification made to the original salicylic acid compound. As an alternative, aspirin is acetylated at the carboxyl group (OH), converting it to acetylsalicylic acid (ASA). This change in chemical structure is essential for ASA's effectiveness in inhibiting platelet aggregation, the formation of blood clots responsible for causing heart attacks and strokes. How does this modification impact ASA's mechanism of action? The acetylation of salicylic acid significantly alters its pharmacological profile, particularly its interaction with COX enzymes. Specifically, ASA's acetylated form irreversibly inhibits COX-1, preventing prostaglandin synthesis, which in turn inhibits platelet aggregation. What differences exist between old and new aspirin formulations? The acetylation of salicylic acid to create ASA is the primary chemical modification made for current antiplatelet use. Other differences might include variations in purity, potency, or formulation, but these differences do not impact the basic mechanism of action or chemical structure of the medication. Can other modifications be made to ASA or salicylic acid for enhanced antiplatelet effects? Researchers are continually exploring modified versions of ASA with improved efficacy or safety profiles. However, such modifications must be carefully evaluated for potential risks and benefits compared to standard ASA products. [1] What regulatory considerations affect the production of acetylsalicylic acid? Regulations related to the production and formulation of ASA often focus on establishing acceptable manufacturing practices and guaranteeing the drug's efficacy, purity, and potency. Aspirin, like other medications, is subject to patent protection and regulatory guidelines that impact patent extension, exclusivity, and generic availability. [2] Sources [1] 'US5183686 A - Improved anti-thrombotic compounds and methods of preparation' by DrugPatentWatch.com. https://drugpatentwatch.com/patent/us5183686A [2] 'US 5238761 A - Solid dispersions of aspirin' by DrugPatentWatch.com. https://drugpatentwatch.com/patent/us5238761A [3] 'Aspirin' in Wikipedia. https://en.wikipedia.org/wiki/Aspirin
Other Questions About Aspirin :